Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...

The battery problems behind a serious recall of Boston Scientific pacemakers have been ongoing for years, according to a New ...

A made-in-Calgary 4D heart model is transforming treatment for heart failure patients having a specialized pacemaker inserted, called cardiac resynchronization therapy (CRT). In a clinical trial, ...

Boston Scientific is recalling Ingenio family of pacemakers (includes models Advantio DR EL, Ingenio DR EL, and Vitalio DR EL) and cardiac resynchronization therapy pacemakers (CRT-Ps) due to the risk ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Robert Canby, a cardiac electrophysiologist, describes an FDA-approved novel lead-less system that provides cardiac ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

A typical implantation of a CRT-P with its three leads and use of an anti-infective envelope would require five ICD-10-PCS codes. Q: We are having trouble with a case that involves an Implantation of ...

Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...

LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global cardiac resynchronization therapy pacemaker (CRT-P) market 2016-2020 report until 2020. Competitive ...

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

Cardiac resynchronization therapy (CRT) is beneficial in patients with New York Heart Association (NYHA) functional class III and IV heart failure and wide QRS duration, especially due to left bundle ...

Dublin, Oct. 09, 2019 (GLOBE NEWSWIRE) -- The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering. The global market for implantable ...